IN2014CN04922A - - Google Patents

Info

Publication number
IN2014CN04922A
IN2014CN04922A IN4922CHN2014A IN2014CN04922A IN 2014CN04922 A IN2014CN04922 A IN 2014CN04922A IN 4922CHN2014 A IN4922CHN2014 A IN 4922CHN2014A IN 2014CN04922 A IN2014CN04922 A IN 2014CN04922A
Authority
IN
India
Prior art keywords
formula
paroxetine
retains
pharmaceutically acceptable
alkyl group
Prior art date
Application number
Other languages
English (en)
Inventor
Keigo Tanaka
Tomoki Nishioka
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of IN2014CN04922A publication Critical patent/IN2014CN04922A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
IN4922CHN2014 2012-01-31 2013-01-29 IN2014CN04922A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261592896P 2012-01-31 2012-01-31
PCT/JP2013/051858 WO2013115163A1 (ja) 2012-01-31 2013-01-29 パロキセチン誘導体

Publications (1)

Publication Number Publication Date
IN2014CN04922A true IN2014CN04922A (es) 2015-09-18

Family

ID=48870749

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4922CHN2014 IN2014CN04922A (es) 2012-01-31 2013-01-29

Country Status (16)

Country Link
US (1) US8933100B2 (es)
EP (1) EP2810942B1 (es)
JP (1) JP6055784B2 (es)
KR (1) KR101950057B1 (es)
CN (1) CN104039777B (es)
AR (1) AR089837A1 (es)
AU (1) AU2013216123B2 (es)
BR (1) BR112014016197A8 (es)
CA (1) CA2861479C (es)
ES (1) ES2576082T3 (es)
IL (1) IL233327A (es)
IN (1) IN2014CN04922A (es)
MX (1) MX355654B (es)
RU (1) RU2616610C2 (es)
TW (1) TW201334783A (es)
WO (1) WO2013115163A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016315720B2 (en) * 2015-09-02 2021-02-25 Trevena, Inc. 6-membered AZA-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
CN110446495B (zh) 2017-02-17 2023-09-05 特维娜有限公司 含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
CN111533682B (zh) * 2020-05-29 2022-03-01 清华大学 帕罗西汀及其类似物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
WO1998056787A1 (en) * 1997-06-10 1998-12-17 Synthon B.V. 4-Phenylpiperidine compounds
IT1308629B1 (it) * 1999-02-23 2002-01-09 Recordati Chem Pharm Processo per la produzione di paroxetina.
KR101380190B1 (ko) * 2005-07-29 2014-04-11 콘서트 파마슈티컬즈, 인크. 벤조 〔d〕〔1,3〕―디옥솔 유도체
US20070142389A1 (en) * 2005-12-20 2007-06-21 Pfizer Inc. Piperidine derivatives
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物

Also Published As

Publication number Publication date
IL233327A (en) 2016-03-31
EP2810942A4 (en) 2015-07-01
EP2810942A1 (en) 2014-12-10
BR112014016197A2 (pt) 2017-06-13
WO2013115163A1 (ja) 2013-08-08
MX2014007620A (es) 2014-09-15
AU2013216123A1 (en) 2014-07-17
RU2616610C2 (ru) 2017-04-18
KR101950057B1 (ko) 2019-02-19
JPWO2013115163A1 (ja) 2015-05-11
RU2014126321A (ru) 2016-03-20
EP2810942B1 (en) 2016-03-30
CN104039777A (zh) 2014-09-10
CN104039777B (zh) 2016-03-02
JP6055784B2 (ja) 2016-12-27
MX355654B (es) 2018-04-26
IL233327A0 (en) 2014-08-31
US20130197033A1 (en) 2013-08-01
BR112014016197A8 (pt) 2017-07-04
TW201334783A (zh) 2013-09-01
CA2861479A1 (en) 2013-08-08
US8933100B2 (en) 2015-01-13
AR089837A1 (es) 2014-09-17
KR20140117454A (ko) 2014-10-07
ES2576082T3 (es) 2016-07-05
AU2013216123B2 (en) 2016-10-20
CA2861479C (en) 2017-10-10

Similar Documents

Publication Publication Date Title
PH12017501429A1 (en) Derivatives of betulin
CA2875877C (en) Syk inhibitors
PH12016501822A1 (en) Cyclopropaneamine compound
PH12017501326A1 (en) Tgf-� inhibitors
AU2012214029A8 (en) Rorgammat inhibitors
AU2012313888A8 (en) 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
MX2015012062A (es) Inhibidores de jak2 y alk2 y metodos para su uso.
IN2014MN01897A (es)
MD20180040A2 (ro) Inhibitori ai virusului hepatic C
MX2016006336A (es) Compuestos pirazolopirimidina.
GEP201606532B (en) Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
MX2014001595A (es) Compuestos de imidazol, composiciones y metodos de uso.
MY180083A (en) Tetrahydropyrrolothiazine compounds
TN2011000400A1 (en) Inhibitors of beta-secretase
RS54526B1 (en) USE OF PIRAZOLOSPIROKETONE DERIVATIVES AS ACETYL-COA CARBOXYLASE INHIBITORS
MY164776A (en) Heterocyclic compound
IN2014DN07509A (es)
IN2012DN00765A (es)
IN2014CN04449A (es)
MY185971A (en) Pyranodipyridine compound
PH12015502032A1 (en) Azetidinyloxyphenylpyrrolidine compounds
IN2014DN07996A (es)
MY170262A (en) Dicarboxylic acid compound
MX359399B (es) Inhibidores de 17alfa-hidroxilasa/c17-20-liasa.
IN2014CN04922A (es)